- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Most Popular Stocks
Swedish Pharmaceuticals & Biotech Most Popular Stocks
Results
98
Most Popular Stocks on the market
98 companies
Swedish Orphan Biovitrum
Market Cap: SEK 118.1b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 342.60
7D
4.3%
1Y
2.6%
BioArctic
Market Cap: SEK 47.7b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 321.20
7D
2.6%
1Y
46.4%
Camurus
Market Cap: SEK 42.0b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 703.50
7D
6.2%
1Y
26.0%
AddLife
Market Cap: SEK 17.6b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 144.10
7D
-1.2%
1Y
-0.07%
Vitrolife
Market Cap: SEK 16.6b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 122.30
7D
-3.9%
1Y
-43.8%
Bonesupport Holding
Market Cap: SEK 12.7b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 192.20
7D
-4.2%
1Y
-43.4%
BioGaia
Market Cap: SEK 11.5b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 113.40
7D
5.8%
1Y
-4.1%
MedCap
Market Cap: SEK 7.6b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 507.00
7D
-1.4%
1Y
38.7%
Swedencare
Market Cap: SEK 5.5b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 34.70
7D
-0.6%
1Y
-27.3%
Hansa Biopharma
Market Cap: SEK 3.9b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 38.40
7D
17.8%
1Y
20.2%
Saniona
Market Cap: SEK 3.6b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 26.20
7D
23.6%
1Y
285.9%
Vicore Pharma Holding
Market Cap: SEK 3.5b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 12.52
7D
11.4%
1Y
48.7%
Flerie
Market Cap: SEK 2.8b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 36.45
7D
-2.5%
1Y
-26.0%
Cereno Scientific
Market Cap: SEK 2.0b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden and internationally.
CRNO B
SEK 6.61
7D
-2.1%
1Y
29.0%
BioInvent International
Market Cap: SEK 2.0b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 31.00
7D
12.3%
1Y
9.9%
Diamyd Medical
Market Cap: SEK 2.0b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 14.22
7D
16.9%
1Y
-19.5%
Egetis Therapeutics
Market Cap: SEK 1.9b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 4.76
7D
7.3%
1Y
-19.4%
Devyser Diagnostics
Market Cap: SEK 1.7b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 103.40
7D
-1.5%
1Y
-18.9%
Genovis AB (publ.)
Market Cap: SEK 1.5b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 22.90
7D
8.5%
1Y
-4.0%
Cantargia
Market Cap: SEK 1.5b
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 5.87
7D
16.9%
1Y
227.2%
BICO Group
Market Cap: SEK 1.3b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 18.19
7D
-1.8%
1Y
-44.0%
SynAct Pharma
Market Cap: SEK 1.2b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 22.00
7D
-5.2%
1Y
93.3%
Orexo
Market Cap: SEK 1.1b
A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 32.20
7D
7.9%
1Y
61.2%
Xspray Pharma
Market Cap: SEK 1.1b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 26.25
7D
3.8%
1Y
-19.7%
Oncopeptides
Market Cap: SEK 904.0m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 3.32
7D
0.5%
1Y
154.2%
Curasight
Market Cap: DKK 608.6m
Develops therapeutic and diagnostic solutions for the treatment of cancer.
CURAS
DKK 12.70
7D
8.5%
1Y
36.6%
Cinclus Pharma Holding
Market Cap: SEK 833.0m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 17.90
7D
-8.0%
1Y
-1.7%
Hamlet BioPharma
Market Cap: SEK 746.3m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.20
7D
14.3%
1Y
1.4%
Cessatech
Market Cap: DKK 461.6m
A pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark.
CESSA
DKK 24.85
7D
19.2%
1Y
110.6%
Infant Bacterial Therapeutics
Market Cap: SEK 654.7m
Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.
IBT B
SEK 48.60
7D
2.9%
1Y
12.2%
Dicot Pharma
Market Cap: SEK 578.7m
Engages in the development of pharmaceutical products in Sweden.
DICOT
SEK 0.29
7D
2.1%
1Y
-8.3%
FluoGuide
Market Cap: SEK 554.2m
A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.
FLUO
SEK 33.90
7D
-2.0%
1Y
-29.7%
Enzymatica
Market Cap: SEK 479.4m
A life science company, develops and sells medical devices for infection-related diseases.
ENZY
SEK 1.98
7D
0.5%
1Y
29.1%
Corline Biomedical
Market Cap: SEK 447.0m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 17.45
7D
-0.6%
1Y
76.3%
Moberg Pharma
Market Cap: SEK 442.7m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 9.42
7D
1.5%
1Y
0.3%
Ascelia Pharma
Market Cap: SEK 367.9m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 2.90
7D
-5.2%
1Y
0.2%